Biosimulations Predict that Rituximab is More Efficacious than Other Standards of Care in Rheumatoid Arthritis Patients with Severe Disease

Biosimulations Predict that Rituximab is More Efficacious than Other Standards of Care in Rheumatoid Arthritis Patients with Severe Disease

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.) Fla.), 2007-01, Vol.123, p.S91-S91
Hauptverfasser: Kretsos, Kosmas, Engineer, Entelos, Inc, Foster City, CA, Young, Daniel L., Engineer, Entelos Inc., Foster City, CA, Whiting, Chan C., Scientist, Entelos, Inc., Foster City, CA, Kudrycki, Katherine, Scientist, Entelos, Inc., Foster City, CA, Kellermann, Sirid-Aimee, Senior Scientist, Entelos, Inc., Foster City, CA, Derfanoux, Nadine A., Senior Scientist, Entelos, Inc., Foster City, CA
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1521-6616
1521-7035
DOI:10.1016/j.clim.2007.03.440